Alzheimer’s and other dementias are underdiagnosed and often diagnosed late, particularly among women, Black people, and Latinos. At the same time, the latest treatments are most effective early in the course of the disease. This panel will explore how cutting-edge innovations—such as blood tests, digital cognitive assessments, and AI—can enhance detection and diagnosis rates for everyone. Key Question: How can we ensure new diagnostic and AI-based tools for Alzheimer's disease address disparities rather than widen them?
